-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Janux Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- Janux Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $7.86M, a 143% increase year-over-year.
- Janux Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $21.9M, a 128% increase year-over-year.
- Janux Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $14.7M, a 264% increase from 2022.
- Janux Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.03M, a 1469% increase from 2021.
- Janux Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $257K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)